|
EskalithDrug - Eskalith The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Lithium Carbonate
Strength -
300MG
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
017971
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Eskalith
Lithonate 300mg Capsule; Oral
Eskalith Cr 450mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Tablet, Extended Release; Oral Lithium Carbonate 450mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Tablet, Extended Release; Oral Lithium Carbonate 450mg Tablet, Extended Release; Oral Lithium Carbonate 450mg Tablet, Extended Release; Oral Lithobid 300mg Tablet, Extended Release; Oral Eskalith 300mg Tablet; Oral NewDrugInformation |